15–34 (n = 666) | 35–59 (n = 1318) | ≥60 (n = 1736) | Total (n = 3720) | p-value | |
---|---|---|---|---|---|
Any drug resistance | 91 (13.7%) | 189 (14.3%) | 230 (13.2%) | 510 (13.7%) | 0.685 |
Resistant to | |||||
INH | 62 (9.3%) | 140 (10.6%) | 153 (8.8%) | 355 (9.5%) | 0.236 |
RIF | 41 (6.2%) | 54 (4.1%) | 42 (2.4%) | 137 (3.7%) | 0.000 |
Rfb | 31 (4.7%) | 33 (2.5%) | 28 (1.6%) | 92 (2.5%) | 0.000 |
EMB | 15 (2.3%) | 38 (2.9%) | 29 (1.7%) | 82 (2.2%) | 0.077 |
PZA | 11 (1.7%) | 22 (1.7%) | 21 (1.2%) | 54 (1.5%) | 0.514 |
Km | 2 (0.3%) | 5 (0.4%) | 11 (0.6%) | 18 (0.5%) | 0.455 |
Am | 2 (0.3%) | 5 (0.4%) | 10 (0.6%) | 17 (0.5%) | 0.584 |
Cm | 3 (0.5%) | 5 (0.4%) | 15 (0.9%) | 23 (0.6%) | 0.198 |
Sm | 26 (3.9%) | 46 (3.5%) | 59 (3.4%) | 131 (3.5%) | 0.832 |
Lfx | 8 (1.2%) | 18 (1.4%) | 18 (1.0%) | 44 (1.2%) | 0.706 |
Mfx | 7 (1.1%) | 14 (1.1%) | 17 (1.0%) | 38 (1.0%) | 0.971 |
Ofx | 8 (1.2%) | 18 (1.4%) | 17 (1.0%) | 43 (1.2%) | 0.608 |
Pto | 6 (0.9%) | 6 (0.5%) | 18 (1.0%) | 30 (0.8%) | 0.196 |
Cs | 0 (0.0%) | 1 (0.1%) | 1 (0.1%) | 2 (0.1%) | 0.785 |
PAS | 3 (0.5%) | 14 (1.1%) | 24 (1.4%) | 41 (1.1%) | 0.145 |
INH-monoresistance | 36 (5.4%) | 99 (7.5%) | 122 (7.0%) | 257 (6.9%) | 0.210 |
RIF-monoresistance | 15 (2.3%) | 13 (1.0%) | 11 (0.6%) | 39 (1.0%) | 0.002 |
Multidrug resistance | 26 (3.9%) | 41 (3.1%) | 31 (1.8%) | 98 (2.6%) | 0.006 |
Resistance to any FQsa | 9 (1.4%) | 18 (1.4%) | 18 (1.0%) | 45 (1.2%) | 0.666 |
Resistance to any SLIDsb | 5 (0.8%) | 6 (0.5%) | 17 (1.0%) | 28 (0.8%) | 0.252 |